Wargacki Stephen
SEC insider (Form 3/4/5 filer). CIK 0001960165. Chief Science Officer at Aquestive Therapeutics, Inc. (AQST). 5 reported Form 4/5 transactions since Sep 2024; latest on Mar 10, 2025. Located in WARREN, NJ.
Companies Wargacki Stephen has filed insider reports for
- Aquestive Therapeutics, Inc. (AQST): Officer, Chief Science Officer
Wargacki Stephen
CIK: 0001960165
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (20.0%)
Compensation grants
Other (G, F, J, C, D, …)4 (80.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
AQST
Aquestive Therapeutics, Inc.
Officer
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Mar 10, 2025AQST
Aquestive Therapeutics, Inc.
Tax PaymentDirect4.6K shares at avg. $2.54$12K - Mar 9, 2025AQST
Aquestive Therapeutics, Inc.
Tax PaymentDirect15.4K shares at avg. $2.65$41K - Mar 7, 2025AQST
Aquestive Therapeutics, Inc.
AwardDirect115K shares- - Mar 7, 2025AQST
Aquestive Therapeutics, Inc.
Tax PaymentDirect12.9K shares at avg. $2.65$34K - Mar 9, 2024AQST
Aquestive Therapeutics, Inc.
Tax PaymentDirect19.5K shares at avg. $4.88$95K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Mar 10, 2025 | AQST Aquestive Therapeutics, Inc. | Tax Payment | 4,572 | $2.54 | $11,613 | Direct |
| Mar 9, 2025 | AQST Aquestive Therapeutics, Inc. | Tax Payment | 15,431 | $2.65 | $40,892 | Direct |
| Mar 7, 2025 | AQST Aquestive Therapeutics, Inc. | Award | 115,000 | - | - | Direct |
| Mar 7, 2025 | AQST Aquestive Therapeutics, Inc. | Tax Payment | 12,859 | $2.65 | $34,076 | Direct |
| Mar 9, 2024 | AQST Aquestive Therapeutics, Inc. | Tax Payment | 19,505 | $4.88 | $95,184 | Direct |
1-5 of 5 transactions